First-line Immunotherapy and Clinically Meaningful Survival Benefits for the Oldest Adults With Lung Cancer. Charlot M, Gray J. JAMA Oncol 2023 Jan 26. doi: 10.1001/jamaoncol.2022.6867.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Charlot M, Gray J. First-line Immunotherapy and Clinically Meaningful Survival Benefits for the Oldest Adults With Lung Cancer. JAMA Oncol 2023 Jan 26. doi: 10.1001/jamaoncol.2022.6867.
PMID: 36701141